Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, October 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Average Attention Score compared to outputs of the same age and source

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 9,503 followers.

RT @emiliomonteb: Cost-effectivness of echinocandins & fluconazole in candidemia and/or invasive candidiasis in nonneutropenic patient http…

RT @emiliomonteb: Cost-effectivness of echinocandins & fluconazole in candidemia and/or invasive candidiasis in nonneutropenic patient http…

RT @emiliomonteb: Cost-effectivness of echinocandins & fluconazole in candidemia and/or invasive candidiasis in nonneutropenic patient http…

RT @emiliomonteb: Cost-effectivness of echinocandins & fluconazole in candidemia and/or invasive candidiasis in nonneutropenic patient http…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.